PharmaShots Interview: Merz Aesthetics’ Dr. Terri Phillips Shares Insight on GP Campaign for Xeomin

In an interview with PharmaShots, Dr. Terri Phillips, Chief Medical Affairs Officer at Merz Aesthetics shared her views on the new campaign with Gwyneth Paltrow for its flagship product Xeomin. She also shed light on Medical Aesthetic treatments during the pandemic and how Merz is working to meet the demand.Shots:Merz Aesthetics collaborates with Gwyneth Paltrow for the launch of the company's first…

BySenior EditorFebruary 27, 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in December 2019 and January 2020

The US FDA's Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 48 new products so far in 2019However, there is a significant increase in multiple diseases while the new approvals are helping and advancing the changes to understand, diagnose and treat the diseasesOur team…

BySenior EditorFebruary 21, 2020

VIEWPOINTS

PharmaShots Interview: Views of Dr. Upendra Kaul and Dr. Anish Desai on DIA Medical Device Conference 2020

The Medical Devices Conference will be hosted by DIA India on 21st and 22nd February in collaboration with Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI Europa, is one of the largest gatherings of medical devices professionals in the region. The conference will be focusing on giving better insights into the challenges…

BySenior EditorFebruary 18, 2020

INSIGHTS+

Insights+ Key Biosimilars Events of January 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyBiosimilar is expanding its footprints worldwide with multiple collaborations. In Jan 2020, Pfizer launched its two biosimilars [Ruxience (biosimilar, rituximab) & Trazimera (biosimilar, trastuzumab)] at lowest WAC in the USOur team at PharmaShots has summarized key…

BySenior EditorFebruary 14, 2020

EVENTS

DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

The Medical Devices Conference hosted by DIA India on 21st and 22nd February in collaboration with Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI Europa, is one of the largest gatherings of medical devices professionals in the region.This initiative is a first for DIA in India and holds promise to…

BySenior EditorFebruary 13, 2020

EVENTS

PUCG 2020 BERLIN Conference

Utilitarian Conferences Gathering offers a wide range of events, Meetings, Conferences, Workshops, Symposium. We have a dedicated team who are aimed at acquiring the technologies, adopting the knowledge of business needs and accelerate with best ideas and strategies. Utilitarian Conferences Gathering is a pioneer in the area of Event Management, Collaboration. We are full…

BySenior EditorFebruary 11, 2020

INSIGHTS+

Insights+: Key Deals of J.P. Morgan Healthcare Conference 2020

The 2020 JP Morgan Healthcare Conference was loaded with insights from key pharma companies. An analysis of events and catalysts that were announced or updated at the conference these days are included. Our PharmaShots team summarized the key deals which were presented during the updates from companies from Jan 13 to Jan 16, 2020.Date…

BySenior EditorFebruary 7, 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – March 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it.The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019.PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where…

BySenior EditorJanuary 31, 2020

INSIGHTS+

PharmaShots’ Key Highlights of Fourth Quarter 2019

1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019Date - Oct 01, 2019Product - Zirabev (biosimilar, bevacizumab)The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept 2019,…

BySenior EditorJanuary 24, 2020

INSIGHTS+

Insights+ Key Biosimilars Events of December 2019

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyIn Dec, 2019 Kamada signed a deal with Alvotech for commercialization of biosimilars in Israel while Techno Science also signed an agreement with Kishi Kasei for co-developing biosimilar afliberceptMylan and Biocon launched its Ogivri (trastuzumab-dkst) in…

BySenior EditorJanuary 17, 2020

Senior Editor

PharmaShots Interview: Merz Aesthetics’ Dr. Terri Phillips Shares Insight on GP Campaign for Xeomin

Insights+: The US FDA New Drug Approvals in December 2019 and January 2020

PharmaShots Interview: Views of Dr. Upendra Kaul and Dr. Anish Desai on DIA Medical Device Conference 2020

Insights+ Key Biosimilars Events of January 2020

DIA India Medical Devices Conference from 21-22 February 2020 I New Delhi, India

PUCG 2020 BERLIN Conference

Insights+: Key Deals of J.P. Morgan Healthcare Conference 2020

Insights+: COVID-19 Healthcare News Monthly Updates – March 2020

PharmaShots’ Key Highlights of Fourth Quarter 2019

Insights+ Key Biosimilars Events of December 2019

Contact US

FOLLOW US